[go: up one dir, main page]

FR3114236B1 - Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire - Google Patents

Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire Download PDF

Info

Publication number
FR3114236B1
FR3114236B1 FR2009617A FR2009617A FR3114236B1 FR 3114236 B1 FR3114236 B1 FR 3114236B1 FR 2009617 A FR2009617 A FR 2009617A FR 2009617 A FR2009617 A FR 2009617A FR 3114236 B1 FR3114236 B1 FR 3114236B1
Authority
FR
France
Prior art keywords
argon
inhaled
treat
patient
cardiovascular disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2009617A
Other languages
English (en)
Other versions
FR3114236A1 (fr
Inventor
Géraldine Farjot
Catherine Billoet
Matthieu Chalopin
Roux Quentin De
Renaud Tissier
Nicolas Mongardon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecole Nat Veterinaire Dalfort
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Air Liquide SA
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Ecole Nationale Veterinaire dAlfort
Universite Paris Est Creteil Val de Marne
Universite de Marne la Vallee
Original Assignee
Ecole Nat Veterinaire Dalfort
Assistance Publique Hopitaux de Paris APHP
Institut National de la Sante et de la Recherche Medicale INSERM
Air Liquide SA
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Ecole Nationale Veterinaire dAlfort
Universite Paris Est Creteil Val de Marne
Universite de Marne la Vallee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecole Nat Veterinaire Dalfort, Assistance Publique Hopitaux de Paris APHP, Institut National de la Sante et de la Recherche Medicale INSERM, Air Liquide SA, LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude, Ecole Nationale Veterinaire dAlfort, Universite Paris Est Creteil Val de Marne, Universite de Marne la Vallee filed Critical Ecole Nat Veterinaire Dalfort
Priority to FR2009617A priority Critical patent/FR3114236B1/fr
Priority to EP21766507.4A priority patent/EP4216967A1/fr
Priority to US18/028,164 priority patent/US20230364130A1/en
Priority to PCT/EP2021/075099 priority patent/WO2022063619A1/fr
Publication of FR3114236A1 publication Critical patent/FR3114236A1/fr
Application granted granted Critical
Publication of FR3114236B1 publication Critical patent/FR3114236B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Titre de l’invention Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire L’invention concerne une utilisation d’argon gazeux administré par inhalation pour préserver et/ou pour protéger l’hémodynamique, notamment pour protéger le débit sanguin cardiaque, d’un patient humain souffrant d’une pathologie cardiovasculaire nécessitant une chirurgie cardiaque ou vasculaire, notamment un anévrisme de l’aorte, une ischémie myocardique ou une insuffisance cardiaque sévère. L’argon est préférentiellement mélangé avec de l’oxygène. Figure de l’abrégé : Fig. 1
FR2009617A 2020-09-23 2020-09-23 Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire Active FR3114236B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR2009617A FR3114236B1 (fr) 2020-09-23 2020-09-23 Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire
EP21766507.4A EP4216967A1 (fr) 2020-09-23 2021-09-13 Argon inhalé pour traiter un patient souffrant d'une pathologie cardiovasculaire
US18/028,164 US20230364130A1 (en) 2020-09-23 2021-09-13 Inhaled argon for treating a patient suffering from cardiovascular disease
PCT/EP2021/075099 WO2022063619A1 (fr) 2020-09-23 2021-09-13 Argon inhalé pour traiter un patient souffrant d'une pathologie cardiovasculaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2009617 2020-09-23
FR2009617A FR3114236B1 (fr) 2020-09-23 2020-09-23 Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire

Publications (2)

Publication Number Publication Date
FR3114236A1 FR3114236A1 (fr) 2022-03-25
FR3114236B1 true FR3114236B1 (fr) 2023-08-04

Family

ID=74125362

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2009617A Active FR3114236B1 (fr) 2020-09-23 2020-09-23 Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire

Country Status (4)

Country Link
US (1) US20230364130A1 (fr)
EP (1) EP4216967A1 (fr)
FR (1) FR3114236B1 (fr)
WO (1) WO2022063619A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3004350A1 (fr) * 2013-04-12 2014-10-17 Air Liquide Delivrance de gaz medical a un receveur de materiel biologique
US10828436B2 (en) * 2016-04-05 2020-11-10 Vanderbilt University Administering the noble gas argon during cardiopulmonary resuscitation
EP3424550A1 (fr) * 2017-07-06 2019-01-09 Monatomics Technology Des mélanges gazeux contenant de faibles concentrations de xénon et de le argon assurer une neuroprotection sans inhiber le activité catalytique d'agents thrombolytiques

Also Published As

Publication number Publication date
US20230364130A1 (en) 2023-11-16
WO2022063619A1 (fr) 2022-03-31
FR3114236A1 (fr) 2022-03-25
EP4216967A1 (fr) 2023-08-02

Similar Documents

Publication Publication Date Title
Kreimeier et al. Hemodilution in clinical surgery: state of the art 1996
Vallabhajosyula et al. Moderate versus deep hypothermic circulatory arrest for elective aortic transverse hemiarch reconstruction
Olsson et al. Antegrade cerebral perfusion with a simplified technique: unilateral versus bilateral perfusion
von Segesser et al. Prevention and therapy of leg ischaemia in extracorporeal life support and extracorporeal membrane oxygenation with peripheral cannulation.
Tomaszuk-Kazberuk et al. Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm
Bauer et al. Evaluation of hemodynamic and regional tissue perfusion effects of minimized extracorporeal circulation (MECC®)
Novellis et al. Venoarterial extracorporeal membrane oxygenation support in lung cancer resection
FR3114236B1 (fr) Argon inhalé pour traiter un patient souffrant d’une pathologie cardiovasculaire
Fujikawa et al. Open surgery for descending thoracic aorta in an endovascular era
Seltzer et al. Decrease in arterial pressure following heparin injection prior to cardiopulmonary bypass
Pontremoli et al. Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria
Chen et al. Radial artery as conduit is safe and effective in coronary bypass surgery in the elderly single-central results from 326 patients
Haithcock et al. Hemodynamic unloading of the failing left ventricle using an arterial-to-arterial extracorporeal flow circuit
Ritz et al. Early epoetin treatment in patients with renal insufficiency
Mejak et al. Cardiopulmonary bypass using argatroban as an anticoagulant for a 6.0-kg pediatric patient
Rukosujew et al. Present-day policy of surgical treatment for type A acute aortic dissection
Fullerton et al. Hemodynamic advantage of left atrial epinephrine administration after cardiac operations
US20250009790A1 (en) Methods for inducing vasodilation
Yamamoto et al. Circulatory Management with Impella Assistance During Off-Pump Coronary Artery Bypass Grafting for Cardiogenic Shock: A Report of Two Cases
Edemskiy et al. Central extracorporeal membrane oxygenation for treatment of reperfusion oedema following pulmonary thromboendarterectomy: a case report
Muhammad et al. Mini Aortic Valve Replacement Converted to Bentall Procedure Secondary to Chronic Type A Aortic Dissection
Safrizal et al. Withdrawn: Perioperative Anaesthesia Management for Aorta Dissection Patient Undergo Bentall Procedure
Zhu Anesthetic Management of Bentall Procedure for a Child with Bicuspid Aortic Valve and Ascending Aorta Dilation
Amano Refinement of Coronary Artery Bypass Grafting at Juntendo University Hospital
Sisto et al. Massive intraoperative pulmonary embolism

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220325

PLFP Fee payment

Year of fee payment: 3

RM Correction of a material error

Effective date: 20220906

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6